Form D — Arialys Therapeutics, Inc.
0002060132-25-000001 · filed Jul 1, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $24,800,006
- Total sold
- $14,800,017
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Arialys Therapeutics, Inc.
- CIK
- 1956823
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 11099 NORTH TORREY PINES ROAD, SUITE 290
LA JOLLA, CA 92037 - Phone
- 858-750-4700
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jay Lichter, Ph.D. · DirectorLa Jolla, CA Find on LinkedIn ↗
-
Brian Slingsby, M.D., Ph.D., M.P.H. · DirectorLa Jolla, CA Find on LinkedIn ↗
-
Ed Hurwitz · DirectorSan Diego, CA Find on LinkedIn ↗
-
Peter Flynn, Ph.D. · Executive OfficerSan Diego, CA Find on LinkedIn ↗
-
Ashish Xavier, Ph.D. · DirectorSan Diego, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗